Bacterial infections

"Bacterial infections" is not the name of a specific molecule or receptor but rather refers broadly to diseases caused by pathogenic bacteria. As such, it does **not** represent a single therapeutic target like an enzyme, receptor, transporter, or other molecular entity. Instead, antibacterial drugs target various essential bacterial structures and processes—including the cell wall, cell membrane, protein synthesis machinery (ribosomes), nucleic acid replication/transcription enzymes, metabolic pathways like folate biosynthesis, and energy production systems such as ATP synthase—to kill bacteria or inhibit their growth[5][6][7]. The term "bacterial infections" describes clinical conditions that are treated with antibiotics; these drugs are classified based on their mechanism(s) of action against different bacterial targets. Because "bacterial infections" is not itself a molecular target but rather an umbrella term for many disease states caused by diverse organisms with varied susceptibilities and pathophysiology—it should **not** be considered as an individual druggable target. **Summary judgment:** "Bacterial infections" is not a valid entry for a canonical therapeutic target; it represents disease states rather than any specific molecule/receptor/enzyme/transporter. Therefore, **is_target = false**, **is_incorrect = true**, and all fields requiring specific molecular information should be set to null.

Other names

Bacterial infectionBacterial diseasesInfections caused by bacteria

*Antibiotics used for bacterial infections act via several mechanisms, including*: - Inhibition of cell wall synthesis (e.g., penicillins, cephalosporins)[5][6][7] - Disruption of cell membrane function (e.g., polymyxins)[5][6] - Inhibition of protein synthesis at the ribosome (e.g., tetracyclines, macrolides)[5][6][7] - Inhibition of nucleic acid synthesis—DNA or RNA synthesis inhibition (e.g., quinolones, rifamycins)[5][6][7] - Inhibition of metabolic pathways such as folate synthesis (e.g., sulfonamides)[5]